Company profile

Future of LyondellBasell Industries

#
Rank
132
| Quantumrun Global 1000

LyondellBasell Industries N.V. (NYSE: LYB) is a public worldwide chemical company with European and American roots. Its operations in America is headquartered in Houston, Texas, with worldwide operations in London, UK. It is incorporated in the Netherlands and was established by the acquisition of Lyondell Chemical Company by Basell Polyolefins for $12.7 billion in December 2007.

Home Country:
Sector:
Industry:
Chemicals
Founded:
2007
Global employee count:
13000
Domestic employee count:
5800
Number of domestic locations:
3

Financial Health

Revenue:
$29183000000 USD
3y average revenue:
$35842000000 USD
Operating expenses:
$229000000 USD
3y average expenses:
$215000000 USD
Funds in reserve:
$875000000 USD
Market country
Revenue from country
0.48
Market country
Revenue from country
0.08
Market country
Revenue from country
0.04

Asset Performance

  1. Product/Service/Dept. name
    Americas segment
    Product/Service revenue
    9077000000
  2. Product/Service/Dept. name
    EAI segment
    Product/Service revenue
    10579000000
  3. Product/Service/Dept. name
    I&D
    Product/Service revenue
    7226000000

Innovation assets and Pipeline

Investment into R&D:
$99000000 USD

All company data collected from its 2016 annual report and other public sources. The accuracy of this data and the conclusions derived from them depend on this publicly accessible data. If a data point listed above is discovered to be inaccurate, Quantumrun will make the necessary corrections to this live page. 

DISRUPTION VULNERABILITY

Belonging to the chemicals sector means this company will be affected directly and indirectly by a number of disruptive opportunities and challenges over the coming decades. While described in detail within Quantumrun’s special reports, these disruptive trends can be summarized along the following broad points:

*First off, artificial intelligence (AI) systems will discover new thousands of new compounds faster than humans that can, compounds that can be applied to everything from creating new makeup to cleaning agents to more effective medicines.

*This automated process of chemical compound discovery will accelerate once AI systems are integrated with mature quantum computers by the late 2020s, allowing these AI systems will compute ever more massive amounts of data.

*As the Silent and Boomer generations enter deep into their senior years by the late 2020s, this combined demographic (30-40 per cent of the global population) will represent a significant financial strain on the health systems of developed nations. This crisis will encourage these nations to fast-track the testing and approval process for new drugs that may improve the overall physical and mental health of patients so that they can lead more independent lives outside of the health care system. The chemical industry will partner with the pharmaceutical industry to address this market need.

COMPANY’S FUTURE PROSPECTS

Company Headlines